Published in

Royal Society of Chemistry, RSC Advances, 72(5), p. 58902-58911, 2015

DOI: 10.1039/c5ra08692b

Links

Tools

Export citation

Search in Google Scholar

Hydroxycinnamic acid as a novel scaffold for the development of cyclooxygenase-2 inhibitors

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Green circle
Postprint: archiving allowed
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

Cyclooxygenase (COX) enzymes are involved in inflammation and cancer. Nine derivatives of hydroxycinnamic acids including ethyl and diethyl esters were synthesized and tested as COX inhibitors in whole blood assay. Esterification improved COX-1 and COX-2 inhibitory activities of the derivatives. Ethyl esters were more effective against COX-1 and the most potent one was caffeic acid ethyl ester. Interestingly, diethyl esters showed selectivity towards COX-2; The most active compound was caffeic acid diethyl ester (CA-DE) with 88.5 and 30.5% inhibitions against COX-2 at 100 and 20 µM, respectively, while it was almost inactive against COX-1. Docking studies showed that CA-DE forms 3 hydrogen bonds with the active site of COX-2 (4-OH..OH-Tyr355, 4-OH..NH-Arg120 and C=O..OH-Tyr385), while it forms only the first two bonds with COX-1. Furthermore, Val523 residue in COX-2 provides a wide hydrophobic pocket, which would accommodate diethyl esters. The present approach inspired by a natural scaffold provides an asset for the generation of new chemical entities endowed with selective COX-2 inhibitory activity.